Share Email Print

Proceedings Paper

Continuous fluorescence depletion anisotropy (CFDA) measurement of protein rotation
Author(s): B. George Barisas; Hongyan Zhang
Format Member Price Non-Member Price
PDF $17.00 $21.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Fluorescence depletion anisotropy (FDA) measurements of protein rotation combine the long lifetime of chromophore triplet states with the sensitivity of the fluorescence excitation and detection. Frequency domain (FDA) addresses certain practical limitations of time-domain procedures, such as the need for detector gating, but presents its own difficulties. We have combined time- and frequency-domain FDA methods into an efficient continuous technique (CFDA). Intensity and polarization of a single laser beam are modulated continuously according to a complex, repetitive waveform and fluorescence signals are averaged over recurring waveform periods by a low rearm time signal averager. Methods for extracting triplet decay and absorption anisotropy decay kinetics from data traces generated by arbitrary waveforms have been developed. For a sample of eosin-BSA in 86% glycerol at 9 degree(s)C, rotational correlation times of 77 micrometers and 137 microsecond(s) , initial anisotropies of 0.109 and 0.125 and limiting anisotropies of 0.017 and 0.022, were obtained by CFDA and cuvet FDA, respectively. Differences in results apparently arise from the weighing of decay components in CFDA by triplet lifetimes of individual components.

Paper Details

Date Published: 10 May 2001
PDF: 9 pages
Proc. SPIE 4260, Optical Diagnostics of Living Cells IV, (10 May 2001); doi: 10.1117/12.426757
Show Author Affiliations
B. George Barisas, Colorado State Univ. (United States)
Hongyan Zhang, Colorado State Univ. (United States)

Published in SPIE Proceedings Vol. 4260:
Optical Diagnostics of Living Cells IV
Daniel L. Farkas; Robert C. Leif; Robert C. Leif, Editor(s)

© SPIE. Terms of Use
Back to Top